Yumanity Therapeutics (NASDAQ: YMTX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Yumanity Therapeutics (NASDAQ: YMTX) through any online brokerage.
The latest price target for Yumanity Therapeutics (NASDAQ: YMTX) was reported by HC Wainwright & Co. on Friday, June 4, 2021. The analyst firm set a price target for 39.00 expecting YMTX to rise to within 12 months (a possible 3413.51% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Yumanity Therapeutics (NASDAQ: YMTX) is $1.11 last updated May 20, 2022, 8:00 PM UTC.
There are no upcoming dividends for Yumanity Therapeutics.
Yumanity Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Yumanity Therapeutics.
Yumanity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.